WebPatricia M. LoRusso, DO, PhD (hc) Professor of Medicine (Medical Oncology); Associate Cancer Center Director, Experimental Therapeutics, Yale School of Medicine, New Haven, Connecticut. For exemplary leadership in drug development and translational cancer therapeutics and for her pioneering work on early phase clinical investigation of novel ... WebJun 6, 2024 · My answer to you is ‘absolutely,’” said Patricia LoRusso, DO, PhD, FASCO, of Yale University, who discussed the implications of the clinical trial findings. “Should the standard of care for patients with HER2-low breast cancer change as a result of the data that Dr. Modi presented today from DESTINY-Breast04?
Patricia M. LoRusso, DO, Joins Yale Cancer Center to Further …
WebDr Patricia LoRusso is Professor of Medicine (Medical Oncology), Yale University/Yale Cancer Center. Dr LoRusso has been a practicing academic medical oncologist … WebPatricia M. LoRusso, DO, PhD (hc) Professor of Medicine (Medical Oncology); Associate Cancer Center Director, Experimental Therapeutics, Yale School of Medicine, New … on this day jan 4
Yale Cancer Center on LinkedIn: Patricia M. LoRusso, DO, PhD …
WebDr LoRusso has been a practicing academic medical oncologist performing clinical/translational research in early phase clinical trials for 30 years, spending the first 25 years at Wayne State University/Karmanos Cancer Institute in Detroit, MI and transitioning to Yale University/Yale Cancer Center in 2014. Web2 days ago · RT @YaleCancer: We are pleased to share that Dr. Patricia LoRusso has been named a Fellow of the @AACR Academy, Class of 2024. The new class will be inducted into the ... WebOncologist Patricia LoRusso, DO, associate director of innovative medicine at Yale Medicine, has expertise in testing new treatments on patient volunteers who have … on this day january